Your First GLP-1 Prescription in 2026: The Landscape Has Completely Changed

If you tried to get a GLP-1 prescription even 18 months ago, you probably hit a wall — shortages, high costs, insurance denials, and limited provider options. The landscape in mid-2026 is dramatically different. New medications, new coverage programs, and a flood of telehealth providers have made access easier than it's ever been.

But more options also means more decisions. This guide walks you through the current landscape so you can show up to your first appointment informed.

What's Available Now (Mid-2026)

FDA-Approved Brand-Name Options

Medication	Type	Format	Typical Retail
Wegovy (semaglutide)	GLP-1	Weekly injection + daily oral	$800–$1,300/mo
Zepbound (tirzepatide)	GLP-1/GIP dual	Weekly injection	$800–$1,100/mo
Foundayo (orforglipron)	GLP-1	Daily oral pill	Varies (new to market)

Compounded Alternatives

Compounded semaglutide and tirzepatide remain available through licensed 503A and 503B pharmacies, typically at $99–$350/month depending on provider and dose. These are the same active ingredients as Wegovy/Zepbound, prepared by licensed pharmacies. They are not FDA-approved products, but they are legal when prescribed by a licensed provider and dispensed by a properly regulated pharmacy.

Cash-Pay and Direct-to-Patient Programs

LillyDirect offers Zepbound and Foundayo through an online platform with various pricing tiers. NovoCare provides savings cards for Wegovy that can reduce costs to as low as $0 for insured patients (and $500/month for cash-pay).

Your Decision Tree

Do you have commercial insurance?

Check your formulary first. Many plans now cover Wegovy and/or Zepbound for obesity with prior authorization. If covered, brand-name is usually the best option. If denied, ask your provider to submit an appeal — denial rates have dropped significantly as coverage has expanded.

Are you on Medicare?

Starting July 1, 2026, the Medicare GLP-1 Bridge covers Foundayo, Wegovy, and Zepbound KwikPen at $50/month. If you qualify, this is your best option. Read our complete Medicare Bridge guide.

Are you paying cash (no insurance coverage)?

Your best options by price point:

• Under $100/mo: GobyMeds compounded semaglutide bundle ($99/mo)
• $100–$200/mo: Embody ($149 first month), Yucca Health ($146+), or Gala ($179/mo flat)
• $200–$400/mo: Wellorithm, Care Bare Rx, or brand-name via LillyDirect
• Brand-name at lowest cost: Sesame Care (pay-per-visit model, brand-name only)

Do you prefer pills over injections?

Your FDA-approved oral options are Foundayo (any time of day, no food restrictions) or oral Wegovy (morning-only, fasting required). For compounded oral options, some providers offer sublingual drops or troches, though these lack the clinical evidence of FDA-approved formulations.

Red Flags in a GLP-1 Provider

More providers means more variation in quality. Watch out for:

• No medical evaluation: Any legitimate provider must conduct a clinical assessment before prescribing
• No follow-up plan: GLP-1 therapy requires ongoing monitoring, especially during titration
• Pricing that seems too good: If a program is charging $50/month for compounded semaglutide, investigate the pharmacy's credentials
• No mention of side effects or contraindications: A provider who doesn't discuss risks isn't providing adequate care
• Pressure to buy supplements or add-ons: The medication is the treatment. Everything else is optional.

What to Bring to Your First Appointment

• Your BMI (calculate it before you go — you need ≥ 30, or ≥ 27 with a comorbidity)
• List of all current medications
• Your weight history and previous weight loss attempts
• Insurance card (including Part D information if Medicare)
• Questions about medication format preference (injectable vs. oral)
• Budget expectations — know what you can afford per month

The barrier to GLP-1 access in 2026 is no longer availability or even cost — it's information. Come prepared, know your options, and work with a provider who takes the time to evaluate you properly.